+ All Categories
Home > Documents > RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™...

RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™...

Date post: 16-Jan-2016
Category:
Upload: nicholas-waters
View: 225 times
Download: 0 times
Share this document with a friend
22
RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis in life sciences, diagnostics and analytical chemistry John Hassard, Department of Physics, Imperial College Founder and CTO deltaDOT www.deltadot.com [email protected] May 11 th 2007
Transcript
Page 1: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

RECFA

Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine

LFII™ technology in High Performance Capillary Electrophoresisin life sciences, diagnostics and analytical chemistry

John Hassard, Department of Physics, Imperial CollegeFounder and CTO deltaDOT www.deltadot.com [email protected]

May 11th 2007

Page 2: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Particle Physics vs Biomedicine

•Funding difficult and getting more so

•Highly evolved scientific methodology – cutting edge technology

•Really interesting – seek simplicity

world pharmaceutical sales

0

250

500

750

1000

1995 2000 2005 2010 2015

$b

n

Series1

Analysecorrelate

Page 3: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Separation and analysis of proteins

• Conventional techniques (CE, MS, HPLC, 2D SDS PAGE…) separate in one or two usually orthogonal dimensions

• Key performance indicators are sensitivity, resolution, quantification accuracy, throughput, dynamic ranges in more than one parameter (eg Mw, concentration)

• Typically, there is a play-off between key parameters. Eg increase in sensitivity can result in decrease in resolving power (more label needed); increase in throughput can lead to less quantification

• LFII is a new approach which rewrites these trade-offs by using proprietary multipixel approach based on HEP algorithms.

Page 4: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Resolution and spectral analyses:

LFII draws on techniques from other disciplines Use spectral information, excellent instrumentation and time-elapse algorithms

Data

Informatio

n

Knowledge

astrophysics

Particle physics

Page 5: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Multipixel Detection and Vertexing

5 positions(214, 254, 280nm)

1:1 image

Standard capillary

512 pixel PDA

UV Light Source

Optics

UV filter

Optics

Detector

Signal

DataProcessing

(GST & EVA)

Separation

512 electropherograms

Page 6: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Generalised Separation Transform

R 1/PTIn a 4 tesla field:

In z-t space in a separation, a similar transform exists in v-space.This allows us to aggregate millions of images from multiple pixels in an unbiased way – the GST

RPair-wise summation of x-y points in 2D space allows a peak in R-space to be developed in an unbiased way hence to find the track in 3D.

Page 7: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

27250

27300

27350

27400

27450

27500

27550

27600

27650

27700

27750

6 8 10 12 14 16 18 20 22

Pixel 250

arb

Time (in mins)

0.000

0.002

0.004

0.006

0.008

0.010

0.012

0.014

6 8 10 12 14 16 18 20

GST

arb

Time (in mins)

• Based on CMSTR – track finder for CMS and work by David Colling and JH : Signal bands move with known velocity function.

• GST takes all pixels and for each time frame and each pixel calculates a velocity which a biomolecule would have to have to reach that pixel at that time.

• This is then histogrammed according to a weight determined by the Beer-Lambert absorption

• This results in an unbiased determination of velocity while retaining all peak shape information

• It requires a ‘virtual vertex’ to be assumed. Equiphase vertexing is a more specific application of GST

• Increases S/N & Retains Peak Shape

Generalised Separation Transform (GST)

Page 8: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Early use of vertexing to identify small signals

Page 9: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

27250

27300

27350

27400

27450

27500

27550

27600

27650

27700

27750

6 8 10 12 14 16 18 20 22

Pixel 250

arb

Time (in mins)

Peak finding

ConstructEquiphase map

• Based on GST, TASSO/Aleph/Babar/D0 vertexing work and work by D. Sideris. The first stage of EVA processing is to perform peak finding on each of the 512 Electropherograms

• The time and amplitude of each peak is determined

• The Equiphase Map is constructed using every identified peak for each pixel

Equiphase Vertexing Algorithm (EVA)

Page 10: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Sample-run profile(Bacterial cell analysis)

Page 11: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

The Vertex

Finding the vertex allows us to identify the unlabelled protein or DNA bands effectively increasing the signal to noise

Single vertexes are generally used but multiple vertexing can also be achieved

Detecting multiple vertices allows higher throughput, improved systematics and allows sample injected at different times to be identified e.g Virtual colour in DNA sequencingWork by Gary Taylor, Phil Lewis, John Hassard and others

Page 12: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Powerful Multipixel Detection Algorithms

Raw Data GST

EVA

Page 13: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Multiple Analyses

Page 14: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Overlay of the EVA processed data of nine consecutive E. coli lysate runs all separated under the same conditions.

Conventional PAGE

Conventional CE

Relative Standard DeviationPeak Time 0.98%Peak Height 4.56%

deltaDOT Peregrine

E.coli Analysis

Page 15: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Glycoproteins

Ribonuclease B Glycoforms

Relative Standard DeviationPeak Time 0.23%Peak Height 3.03%

Page 16: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Analysis of Antibody Standard

An overlay of EVA-processed data of 8 consecutive runs of Beckman Control Standard IgG in denaturing condition.

Page 17: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Peptide Standards Molecular weights (Da):

1.Leucin enkephalin: 555 2.Bradykinin fragment: 572 3.Methionine enkephalin: 573 4.Bradykinin: 1059 5.Oxytocin: 1009 6.[Arg8]- Vasopressin: 10877.Luteinising hormone releasing hormone: 1207 8.Substance P: 13479.Bombesin: 1638

deltaDOT data

Relative Standard DeviationPeak Time 0.44%Peak Height 2.98%

Peptide analysis

Page 18: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Bacteria & Viruses

Baculovirus.

Dilution series on stock 2.9E7 pfu/mL.1:10 1:20 1:30 1:40

In this initial experiment the peaks show a small variation, the peaks correspond to the dilution colour.

y = 0.0011x + 1E-05

R2 = 0.956

0

0.00005

0.0001

0.00015

0.0002

0.00025

0.0003

0 0.05 0.1 0.15 0.2 0.25

Panel A (single pixel) Panel B (512 pixels EVA data)

Escherichia coli.

Good linearity is shown in the initial data set, further experiments are in progress

Page 19: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Advantages of LFIITM in chips

• High sensitivity, quantification, dynamic range

• High Resolution

• Possibility for multiple simultaneous injections

• Reduced Cost

• S/N L, compared to S/N L3 for labelled systems

Page 20: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Latest chip DNA data

Page 21: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Particle physics inputs

• Algorithms• Detectors• Grid• Materials• Techniques (eg Babar ADC approach)• Problem solving approach

• I’d be happy to discuss any ideas you have ([email protected])

Page 22: RECFA Label-Free Intrinsic Imaging- LFII™ Particle Physics and the Future of Biomedicine LFII™ technology in High Performance Capillary Electrophoresis.

Conclusions

• We have established LFII as the most promising new approach in biotechnology. At the heart of the world’s biggest rapid vaccine development program

• LFII rewrites and reduces the compromises inherent in separation technologies, using a multisensor approach derived from other fields. Analysis power is a combination of several parameters, and LFII optimises this.

• LFII is agnostic as to target, and allows powerful relatively bias-free approaches to analysis

• LFII is based entirely on things particle physicists take for granted

• Particle physics cannot take for granted the continued goodwill and funding from governments without a redoubling of effort to show wealth creation.


Recommended